|
LRIG3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.222800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.524950E-03 |
| Normal-vs-Stage2 |
1.448200E-04 |
| Normal-vs-Stage3 |
1.571540E-04 |
| Normal-vs-Stage4 |
9.92020000000204E-05 |
| Stage1-vs-Stage2 |
6.083800E-02 |
| Stage1-vs-Stage3 |
6.767700E-02 |
| Stage1-vs-Stage4 |
4.075700E-02 |
| Stage2-vs-Stage3 |
4.546800E-01 |
| Stage2-vs-Stage4 |
6.633800E-01 |
| Stage3-vs-Stage4 |
7.528200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.27899999999793E-05 |
| Normal-vs-AfricanAmerican |
5.098300E-03 |
| Normal-vs-Asian |
2.000200E-01 |
| Caucasian-vs-AfricanAmerican |
9.440600E-01 |
| Caucasian-vs-Asian |
4.048000E-02 |
| AfricanAmerican-vs-Asian |
1.142610E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.433780E-04 |
| Normal-vs-Female |
1.211640E-04 |
| Male-vs-Female |
2.096800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.881200E-03 |
| Normal-vs-Age(41-60Yrs) |
3.005900E-04 |
| Normal-vs-Age(61-80Yrs) |
2.42669999994671E-06 |
| Normal-vs-Age(81-100Yrs) |
1.126400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.729000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.061520E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.259010E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.132110E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.932210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.732000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.296800E-01 |
| Classical-VS-Follicular |
1.800540E-04 |
| Classical-VS-Other |
3.346500E-02 |
| Classical-VS-Normal |
7.082800E-03 |
| Tall-VS-Follicular |
8.669700E-02 |
| Tall-VS-Other |
3.441600E-01 |
| Tall-VS-Normal |
2.224100E-03 |
| Follicular-VS-Other |
8.257800E-01 |
| Follicular-VS-Normal |
2.01499999996635E-06 |
| Other-VS-Normal |
4.613800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.73180000000639E-05 |
| Normal-vs-N1 |
3.837700E-03 |
| N0-vs-N1 |
7.819600E-01 |
|
|
